Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Find out how to effectively incorporate income statements into your financial planning. This tool can improve your financial insights.
21,698 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
CoreWeave is expanding fast on the AI cloud frontier, but heavy borrowing and rising interest expenses are pulling th...
Quantum investing is no longer a dream. This practical guide weighs D-Wave Quantum’s potential, the risks, and steps ...
The World Liberty Forum opens with WLFI up 18%, highlighting renewed investor interest in crypto assets as policymake...
Apple is reportedly adopting a Netflix style strategy, focusing on originals, bundling, and scalable growth. This art...
A prototype AI agent reportedly moved an entire Lobstar token stake to a social-media reply target, booked quick prof...
When Amazon signaled massive AI and data center investments, its stock tumbled. This guide explains why that drop cou...
A Bermuda-based platform focused on institutional crypto options closes a $30 million round led by CMT Digital, with ...
Analysts are warming to a pair of fintech names as valuations cool and growth metrics improve. This report explains w...
A federal judge sent Nevada's cases against Kalshi and Polymarket back to state court, opening the door for temporary...
Duquesne Family Office reveals a sizable XLF position in its Q4 2025 filings, marking one of the boldest bets on fina...
NVIDIA signals a potential shift in its OpenAI investment with new discussions about winding down the stake. The news...